Nurse Practitioner in Prentice, WI Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Melissa Dawn Belle, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1511 Railroad Ave, Prentice, WI 54556 Phone: 715-428-2521 Fax: 715-428-2522 |
Mary Beth Reynolds, FNP-BC, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1511 Railroad Ave, Prentice, WI 54556 Phone: 715-428-2521 Fax: 715-428-2522 |
News Archive
Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI
Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun enrollment in the SHIELD II U.S. clinical trial examining the HeartMate PHP in patients undergoing a high-risk PCI (percutaneous coronary intervention) procedure.
Experts to address factors that cause low dairy consumption in low- and middle-income countries
Low dairy consumption is common among low- and middle-income countries (LMICs); however, with the demand for milk in these countries projected to increase over the next few decades, there is an opportunity to improve the lives of millions of people from the nutritional benefits of dairy products.
New NTD Special Envoys to focus on eliminating NTD primarily on LAC region
Today, the Global Network for Neglected Tropical Diseases, a major initiative of the Sabin Vaccine Institute, announced His Excellency, President Alvaro Arz- Irigoyen of Guatemala (1996-2000), His Excellency, President Ricardo Lagos Escobar of Chile (2000-2006) and former Pan American Health Organization Director Dr. Mirta Roses Periago as the organization's newest Neglected Tropical Disease Special Envoys.
Yale study questions accuracy of relying on patient death rates to compare hospital quality
Hospitals, health insurers and patients often rely on patient death rates in hospitals to compare hospital quality. Now a new study by researchers at Yale School of Medicine questions the accuracy of that widely used approach and supports measuring patient deaths over a period of 30 days from admission even after they have left the hospital.
Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit
Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that its planned clinical trial of the Company's proprietary zinc-based therapy for patients suffering from amyotrophic lateral sclerosis, also known as Lou Gehrig's Disease, will be featured during the Hot Topics session at the 2011 California ALS Research Summit on Saturday, October 1, 2011.
› Verified 1 days ago